Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 374.2 INR 0.53% Market Closed
Market Cap: 187B INR
Have any thoughts about
Eris Lifesciences Ltd?
Write Note

Eris Lifesciences Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eris Lifesciences Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Eris Lifesciences Ltd
NSE:ERIS
Deferred Income Tax
â‚ą5.4B
CAGR 3-Years
122%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Deferred Income Tax
â‚ą841m
CAGR 3-Years
43%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Deferred Income Tax
â‚ą1.9B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Deferred Income Tax
â‚ą1.9B
CAGR 3-Years
59%
CAGR 5-Years
28%
CAGR 10-Years
-2%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Deferred Income Tax
â‚ą7.9B
CAGR 3-Years
112%
CAGR 5-Years
N/A
CAGR 10-Years
20%
M
Mankind Pharma Ltd
NSE:MANKIND
Deferred Income Tax
â‚ą890.7m
CAGR 3-Years
90%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Eris Lifesciences Ltd
Glance View

Market Cap
186.9B INR
Industry
Pharmaceuticals

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-06-29. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The firm's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

ERIS Intrinsic Value
1 082.77 INR
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Eris Lifesciences Ltd's Deferred Income Tax?
Deferred Income Tax
5.4B INR

Based on the financial report for Jun 30, 2024, Eris Lifesciences Ltd's Deferred Income Tax amounts to 5.4B INR.

What is Eris Lifesciences Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
60%

Over the last year, the Deferred Income Tax growth was 111%. The average annual Deferred Income Tax growth rates for Eris Lifesciences Ltd have been 122% over the past three years , 60% over the past five years .

Back to Top